Book a demo
Book a demo

Neotropix

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Neotropix - overview

Established

2003

Location

Malvern, PA, US

Primary Industry

Biotechnology

About

Founded in 2003, Neotropix is a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers.


Current Investors

Aurora Funds, VIMAC Ventures, Quaker Partners Management

Request a demo

Primary Industry

Biotechnology

Sub Industries

Biotechnology, Oncology/Cancer Treatment

Website

www.neotropix.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Sign in
Request demo